QuestionSBA
QuestionChoice
Ticagrelor is associated with causing breathlessness, not prasugrel. Prasugrel is also an anti-platelet agent and can be used alongside aspirin in patients undergoing percutaneous coronary intervention (PCI).
10003927
b
Prasugrel
QuestionChoice
Ticagrelor is associated with causing breathlessness, not simvastatin. Simvastatin is a statin and can be used for the secondary prevention of myocardial infarctions along with other drugs. Statins reduce cholesterol in the blood.
10003930
e
Simvastatin
QuestionChoice
Ticagrelor is associated with causing breathlessness, not bisoprolol. Bisoprolol is a beta-blocker and can be used for the secondary prevention of myocardial infarctions along with other drugs.
10003929
d
Bisoprolol
QuestionChoice
Ticagrelor is associated with causing breathlessness, not lisinopril. Lisinopril is an ACE inhibitor and can be used for the secondary prevention of myocardial infarctions along with other drugs.
10003928
c
Lisinopril
QuestionChoice
Ticagrelor is an anti-platelet agent and breathlessness is a common side effect associated with it due to the impaired clearance of adenosine. Adenosine can stimulate sensory nerve fibres in the lungs, causing the sensation of breathlessness.
10003926
a
Ticagrelor
Concept
Chapter
2693
4217
Ticagrelor
Topic
169
Cardiovascular pharmacology
13332
A 42-year-old man is admitted to the Coronary Care Unit after experiencing central crushing chest pain. His ECG showed ST elevation.

He received percutaneous coronary intervention and was started on secondary prevention medications. He soon complains of breathlessness.

Which of the following drugs is the most likely cause of his breathlessness?
a